Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Asberg

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Journal of Affective Disorders|April 21, 2001
A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS)P Svanborg, M Asberg
Acta Psychiatrica Scandinavica|January 1, 1994
A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating ScaleP Svanborg, M Asberg
Progress in Neuro-Psychopharmacology|January 1, 1979
Construction of a new psychiatric rating instrument, the Comprehensive Psychopathological Rating Scale (CPRS)M Asberg, D Schalling
Pharmacology|January 1, 1972
Ophthalmological effects of nortriptyline--relationship to plasma levelM Asberg, M Germanis
Clinical Neuropharmacology|January 1, 1993
Serotonin selective antidepressant drugs: past, present, futureM Asberg, B Mårtensson
Advances in Experimental Medicine and Biology|January 1, 1981
Studies of CSF 5-HIAA in depression and suicidal behaviourM Asberg, L Träskman
Ciba Foundation Symposium|January 1, 1986
Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine bindingM Asberg, A Wägner
International Clinical Psychopharmacology|June 1, 1992
Suicide risk and serotoninP Nordström, M Asberg
Neuropsychobiology|March 11, 1999
Variations in CSF monoamine metabolites according to the season of birthJ Chotai, M Asberg
Clinical Neuropharmacology|January 1, 1992
Serotonergic antidepressants--past, present, and futureM Asberg, B Mårtensson
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Journal of Affective Disorders|April 21, 2001
A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS)P Svanborg, M Asberg
Acta Psychiatrica Scandinavica|January 1, 1994
A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating ScaleP Svanborg, M Asberg
Progress in Neuro-Psychopharmacology|January 1, 1979
Construction of a new psychiatric rating instrument, the Comprehensive Psychopathological Rating Scale (CPRS)M Asberg, D Schalling
Pharmacology|January 1, 1972
Ophthalmological effects of nortriptyline--relationship to plasma levelM Asberg, M Germanis
Clinical Neuropharmacology|January 1, 1993
Serotonin selective antidepressant drugs: past, present, futureM Asberg, B Mårtensson
Advances in Experimental Medicine and Biology|January 1, 1981
Studies of CSF 5-HIAA in depression and suicidal behaviourM Asberg, L Träskman
Ciba Foundation Symposium|January 1, 1986
Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine bindingM Asberg, A Wägner
International Clinical Psychopharmacology|June 1, 1992
Suicide risk and serotoninP Nordström, M Asberg
Neuropsychobiology|March 11, 1999
Variations in CSF monoamine metabolites according to the season of birthJ Chotai, M Asberg
Clinical Neuropharmacology|January 1, 1992
Serotonergic antidepressants--past, present, and futureM Asberg, B Mårtensson
Pageof 14